Error: Could not add to watchlist. X
+ Watchlist

Nivalis Therapeutics Inc

34L:GR
Frankfurt
3.74
EUR
0.02
0.43%
As of 3:15 AM EDT 4/29/2016
Open
3.74
Day Range
3.74 - 3.74
Volume
0
Previous Close
3.76
52Wk Range
3.40 - 17.24
Open
3.74
Day Range
3.74 - 3.74
Volume
0
Previous Close
3.76
52Wk Range
3.40 - 17.24
YTD Return
-50.67%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
57.828
Shares Outstanding (m)
15.462
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Nivalis Therapeutics, Inc. operates as a clinical stage pharmaceutical company. The Company focuses on developing a portfolio of small molecule therapeutics for the treatment of major diseases such as cystic fibrosis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, and certain cardiovascular disorders.
Address
3122 Sterling Circle
Suite 200
Boulder, CO 80301
United States
Phone
1-720-945-7700
Show More